KETOPROFEN IN THE MANAGEMENT OF OSTEOARTHROSIS OF THE HIP: COMPARISON WITH PHENYLBUTAZONE

1 August 1974

journal article
clinical trial
Published by Oxford University Press (OUP) in Rheumatology

Vol. 13 (3) , 125-131
https://doi.org/10.1093/rheumatology/13.3.125

Abstract

In a double-blind comparative study in 47 patients with osteoarthrosis of the hip it has been shown that there is little to choose in efficacy between ketoprofen 200 mg. daily and phenylbutazone 300 mg. daily. There were no significant differences in any of the parameters measured. Side-effects were mild in both groups, and no significant changes occurred in haematological and biochemical investigations carried out.

Keywords

DOUBLE
KETOPROFEN
OSTEOARTHROSIS
HAEMATOLOGICAL
EFFICACY
SIDE
CHOOSE
HIP
NO SIGNIFICANT
COMPARISON WITH PHENYLBUTAZONE